Diagnostics News and Research

RSS

FCC makes recommendations for using high-speed broadband networks to increase use of telemedicine

Emerging Healthcare Solutions, Inc. was pleased on learning that The Federal Communication Commission’s national strategy for broadband issued today emphasizes health care, including electronic health record adoption and use, health data exchanges, telemedicine and mobile health services.

18 Mar 2010

Enzo Biochem announces supply and distribution agreement between Enzo Life Sciences and Cancer Genetics

Enzo Biochem, Inc., a vertically integrated biotechnology company engaged in the research, development, manufacture, licensing and marketing of innovative health care products, platforms and services based on molecular and cellular technologies, announced today a supply and distribution agreement between Enzo Life Sciences and privately-owned Cancer Genetics Inc., a leading producer of nucleic acid products used in genomic research.

18 Mar 2010

Agendia to participate in groundbreaking clinical trial for breast cancer

Agendia, a world leader in molecular cancer diagnostics, announced today it will participate in the highly anticipated I-SPY 2 TRIAL for breast cancer, set to launch at the first of nearly twenty research sites.

18 Mar 2010

Biomoda enters into agreements with syndicate of institutional investors for up to $2.0M

Cancer diagnostics company Biomoda, Inc. (www.biomoda.com) today announced that it has entered into agreements with a syndicate of institutional investors for up to $2.0 million. LifeTech Capital, a division of Aurora Capital LLC, acted as the exclusive placement agent for the financing.

17 Mar 2010

HDC, SPM enter into development and licensing agreements with Quest Diagnostics

Health Discovery Corporation and Smart Personalized Medicine, LLC announced today that they have entered into development and related licensing agreements with Quest Diagnostics Incorporated, the world’s leading provider of diagnostic testing, information and services.

From Quest Diagnostics 17 Mar 2010

Meridian Bioscience revises fiscal 2010 guidance, expects net sales between $145M and $153M

Meridian Bioscience, Inc., Cincinnati, Ohio today announced that it is revising downward its previous sales and earnings guidance for the fiscal year ending September 30, 2010. This action is being taken as a result of weaker than expected operating results for the second quarter ending March 31, 2010, based on preliminary results to date. Separately, Meridian announced that it will file a 510(k) for FDA marketing clearance next week in connection with its illumigene™ C. difficile product.

17 Mar 2010

Researchers develop new analytical method to process large amounts of information faster

Researchers at North Carolina State University have developed a new analytical method that opens the door to faster processing of large amounts of information, with applications in fields as diverse as the military, medical diagnostics and homeland security.

17 Mar 2010

MedSolutions launches oncology management program for cancer patients

MedSolutions (www.medsolutions.com), a leading provider of medical cost management services, today announced the launch of its oncology management program, which uses evidence-based guidelines to ensure appropriate use of diagnostic imaging, radiation therapy and drugs for cancer patients.

17 Mar 2010

Celerus Diagnostics to present Wave RPD totally automated HC staining system at annual USCAP meeting

Celerus Diagnostics will introduce a totally automated immunohistochemistry (IHC) staining system, the much-anticipated Wave RPD, at the United States and Canadian Association of Pathologists (USCAP) annual meeting being held in Washington DC, March 22–24. The new system is the first of its kind, capable of delivering totally automated IHC results in one hour.

17 Mar 2010

LUMC purchases Fluidigm Access Array system

Fluidigm Corporation and BIOKÉ, distributor of Fluidigm systems in the Benelux, today announced that Leiden University Medical Center’s (LUMC) Human Genetics Department has purchased a Fluidigm Access Array™ system. The Access Array system enables users to automatically prepare sequencing-ready libraries from up to 48 individual samples at a time, for as little as €7 (EUR) per sample.

16 Mar 2010

Iverson Genetic Diagnostics to conduct WARFARIN clinical study

Iverson Genetic Diagnostics, Inc. today announced that they will conduct a WARFARIN clinical study to assess the efficacy of gene-based testing prior to initiating warfarin anticoagulation therapy to reduce the incidence of bleeding and thromboembolic events.

16 Mar 2010

Nova Century Scientific to market and sell Diamedix’ products in Canada

IVAX Diagnostics, Inc., a fully integrated global invitro diagnostics company, announced that its subsidiary, Diamedix Corporation, has signed a distribution agreement with Nova Century Scientific (“Nova”), a leading Canadian distributor and manufacturer of diagnostic kits and laboratory supplies. Through this agreement, which marks IVAX Diagnostics’ entry into the Canadian market, Nova will market and sell 50 of Diamedix’s products, including analyzer instrumentation, under the Diamedix brand.

16 Mar 2010

Itamar, Roche sign agreement to use EndoPAT device in phase II study for patients with PAD

Itamar announced today that it signed an agreement with Roche for use of Itamar’s EndoPAT device in a clinical phase II study for patients with Peripheral Arterial Disease (PAD) at 80 worldwide medical centers.

16 Mar 2010

Roche Diagnostics named sole source supplier for Premier's blood glucose monitoring devices

Roche Diagnostics announced today that it has been awarded contracts for blood glucose monitoring and clinical chemistry/immunoassay lab analyzers from Premier Purchasing Partners, L.P., Inc., the group purchasing unit of Premier, Inc. Roche was also named the sole source supplier for blood glucose in Premier's exclusive ASCEND supply chain performance program.

From Roche Sequencing and Life Science 16 Mar 2010

GE Healthcare introduces OSA diagnostic tool for inpatient cardiac patients

GE Healthcare today introduced MARS® Virtual Sleep Lab (VSL), the first device to provide a streamlined view of quantitative cardiac and sleep apnea analysis from any GE-monitored inpatient bed, helping enhance speed of diagnosis.

16 Mar 2010

Home Diagnostics merges with Nippon Product Acquisition

Nipro Corporation today announced the successful completion of a short-form merger of Home Diagnostics, Inc. with Nipro’s wholly-owned subsidiary, Nippon Product Acquisition Corporation.

16 Mar 2010

Enzo Biochem to market MultiGEN’s multiplex DNA sequencing based diagnostic tests in state of New York

Enzo Biochem, Inc. today announced that it has entered into an agreement with MultiGEN Diagnostics Inc., of San Diego, California, for exclusive rights to market MultiGEN’s unique diagnostic tests based on multiplex DNA sequencing, in the state of New York. In addition, Enzo has been granted marketing rights for other non-exclusive territories in United States.

15 Mar 2010

RadNet's 2009 fourth-quarter revenue up 3.4%

RadNet, Inc., a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 180 fully-owned and operated outpatient imaging centers, today reported financial results for its fourth quarter and full year ended December 31, 2009.

15 Mar 2010

Roche Diagnostics purchases NimbleGen microarray workflow assets from BioMicro Systems

Roche Diagnostics has purchased assets from BioMicro Systems for all products associated with the Roche NimbleGen microarray workflow. These assets consist of key instrumentation in the comprehensive Roche NimbleGen microarray workflow including the NimbleGen Hybridization Systems (both 4- and 12-bay models).

12 Mar 2010

bioMerieux introduces FDA cleared chromID VRE for detecting Enterococcus faecium and Enterococcus faecalis

bioMerieux – a world leader in the field of in vitro diagnostics – today announced the launch of the first Food and Drug Administration (FDA) cleared chromID™ VRE, a simple and cost-effective solution in the struggle against vancomycin-resistant enterococci (VRE). chromID VRE is the first to receive an FDA 510(k) clearance for the qualitative detection of Enterococcus faecium and Enterococcus faecalis showing acquired resistance to vancomycin in stool specimens.

12 Mar 2010

Diagnostics News and Research

FCC makes recommendations for using high-speed broadband networks to increase use of telemedicine

Enzo Biochem announces supply and distribution agreement between Enzo Life Sciences and Cancer Genetics

Agendia to participate in groundbreaking clinical trial for breast cancer

Biomoda enters into agreements with syndicate of institutional investors for up to $2.0M

HDC, SPM enter into development and licensing agreements with Quest Diagnostics

Meridian Bioscience revises fiscal 2010 guidance, expects net sales between $145M and $153M

Researchers develop new analytical method to process large amounts of information faster

MedSolutions launches oncology management program for cancer patients

Celerus Diagnostics to present Wave RPD totally automated HC staining system at annual USCAP meeting

LUMC purchases Fluidigm Access Array system

Iverson Genetic Diagnostics to conduct WARFARIN clinical study

Nova Century Scientific to market and sell Diamedix’ products in Canada

Itamar, Roche sign agreement to use EndoPAT device in phase II study for patients with PAD

Roche Diagnostics named sole source supplier for Premier's blood glucose monitoring devices

GE Healthcare introduces OSA diagnostic tool for inpatient cardiac patients

Home Diagnostics merges with Nippon Product Acquisition

Enzo Biochem to market MultiGEN’s multiplex DNA sequencing based diagnostic tests in state of New York

RadNet's 2009 fourth-quarter revenue up 3.4%

Roche Diagnostics purchases NimbleGen microarray workflow assets from BioMicro Systems

bioMerieux introduces FDA cleared chromID VRE for detecting Enterococcus faecium and Enterococcus faecalis

Industry Focus eBook - Biotechnology (4th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News